Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Times Interest Earned (2021 - 2025)

Bicycle Therapeutics' Times Interest Earned history spans 5 years, with the latest figure at $2941.3 for Q4 2025.

  • For Q4 2025, Times Interest Earned rose 326.04% year-over-year to $2941.3; the TTM value through Dec 2025 reached -$265.54, down 118.89%, while the annual FY2025 figure was -$265.54, 118.89% down from the prior year.
  • Times Interest Earned reached $2941.3 in Q4 2025 per BCYC's latest filing, up from -$1489.8 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $2941.3 in Q4 2025 to a low of -$1934.7 in Q3 2024.
  • Average Times Interest Earned over 5 years is -$266.18, with a median of -$45.37 recorded in 2022.
  • The largest YoY upside for Times Interest Earned was 326.04% in 2025 against a maximum downside of 3463.33% in 2025.
  • A 5-year view of Times Interest Earned shows it stood at -$21.98 in 2021, then crashed by 77.41% to -$39.0 in 2022, then tumbled by 69.61% to -$66.14 in 2023, then plummeted by 1867.35% to -$1301.2 in 2024, then surged by 326.04% to $2941.3 in 2025.
  • Per Business Quant, the three most recent readings for BCYC's Times Interest Earned are $2941.3 (Q4 2025), -$1489.8 (Q3 2025), and -$1603.7 (Q2 2025).